
X
Sanofi to pay back Philippines after Dengue vaccine problems
https://pharmaphorum.com/news/sanofi-reimburse-philippines-dengue-vaccine-scandal/
Market Access
A further 3,400 children are eligible for treatment with Orkambi
Spark offers efficacy-based rebates and deferred payments to mitigate costs
Strimvelis is most expensive drug cleared by NICE